Your First Space Experiment: A Practical Guide
Step-by-step guide to launching your first microgravity research mission.
Step-by-step guide to launching your first microgravity research mission.
Why microgravity transforms biomedical models for personalized medicine breakthroughs.
Solving "Undruggable" Targets with Perfect Crystals
SPARK Microgravity Brings Orbital Oncology Vision to ORBIT FOR LIFE Roundtable at Roche Diagnostics
How removing gravity reveals new insights in cancer research.
How microgravity reveals truer tumor behavior than traditional models.
Meet the startup who won #1 EU Deep Tech Award 2025
How cancer's behavior in space reveals new therapeutic targets.
Unlocking Cancer’s Secrets in Microgravity
SPARK Microgravity announces plans for Europe’s first commercial cancer lab in space at Frontiers Science House in Davos
How microgravity enables better drug design and novel formulations.
Cancer’s challenge and why SPARK is researching it in space?
SPARK Microgravity GmbH has clinched the top honor at the Barcelona Deep Tech Summit 2025, taking home the #1 EU Deep Tech Champion Award.
SPARK Microgravity’s leadership engaged with partners including Atmos Space Cargo, Space Cargo Unlimited, and Merck Sharp & Dohme (MSD)
A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.
SPARK Microgravity Completes First Rocket Launch, Marking a Major Milestone Toward Orbital Cancer Research
SPARK Microgravity has successfully completed its integration campaign with Swedish Space Corporation (SSC).
SPARK Microgravity's co-founders share their space research mission during an interview at Barcelona Deep Tech Week 2025.
The clear ROI of orbital labs for oncology R&D.
Two female founders are pioneering the next frontier in oncology.
How microgravity enables better drug design and novel therapeutic formulations.
A data-driven look at the market for orbital oncology research.
Allison Bajet, joined an exceptional group of internationally recognized space leaders at Frontiers Science House in Davos for the session “The Space Technology Revolution".
Why 2D and animal models fail and how microgravity bridges translation.
Why space research is essential, not obsolete, for modern oncology.
SPARK’s presence at Frontiers Science House reflects a broader momentum around the company as it continues to develop its orbital oncology platform.
Real case studies prove ROI of microgravity-enabled pharma innovation.
Solving "Undruggable" Targets with Perfect Crystals
Unlocking Cancer’s Secrets in Microgravity
Cancer’s challenge and why SPARK is researching it in space?
The clear ROI of orbital labs for oncology R&D.
How microgravity enables better drug design and novel therapeutic formulations.
How removing gravity reveals new insights in cancer research.
Two female founders are pioneering the next frontier in oncology.
A data-driven look at the market for orbital oncology research.
A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.
Why 2D and animal models fail and how microgravity bridges translation.
How microgravity reveals truer tumor behavior than traditional models.
Step-by-step guide to launching your first microgravity research mission.
Real case studies prove ROI of microgravity-enabled pharma innovation.
How cancer's behavior in space reveals new therapeutic targets.
How microgravity enables better drug design and novel formulations.
Why space research is essential, not obsolete, for modern oncology.
Why microgravity transforms biomedical models for personalized medicine breakthroughs.
From orbit to clinic, let’s launch the future of healthcare, together.
.svg)
